Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Ramaswamy R, Grover H, Corpuz M, Daniels P, Pikhumoni C. Prognostic criteria in Clostridium difficile colitis. Am J Gastroenterol. 1996;91(3):460–4.
2. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34(3):346–53.
3. Kenneally C, Rosini JM, Skrupky LP, et al. Analysis of 30-day mortality for Clostridium difficile-associated disease in the icu setting. Chest. 2007;132(2):418–24.
4. CDC. 2019 AR threats report. https://www.cdc.gov/drugresistance/biggest-threats.html#cdiff. https://doi.org/10.15620/cdc:82532. Accessed 5 Jan 2024
5. Shrestha A, Kalapurayil M, Bailey J, Deol H, Singh R, Surani S. Examining risk of C difficile infection with use of proton pump inhibitor vs H2 receptor antagonist. Chest. 2018;154(4):374A.